Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
40 participants
INTERVENTIONAL
2009-11-30
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental arm
Embryos cultured in SMART System
SMART System
microfluidic embryo culture system
Control
Embryos cultured in microdrops in dishes
Culture dish
Standard IVF culture dish
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMART System
microfluidic embryo culture system
Culture dish
Standard IVF culture dish
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. First or second IVF cycle
3. Not pregnant
4. No physical abnormalities that would adversely affect oocyte retrieval
5. Male factor is acceptable
6. ICSI is acceptable
7. 10 zygotes or more
Exclusion Criteria
2. The embryos were created with either donor oocytes or donor sperm.
3. Medical condition precluding a safe pregnancy
4. Medical condition disqualifying the subject from safely participating in the study in the judgment of the investigator
21 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Incept BioSystems, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Incept BioSystems, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas B Pool, Ph.D., HCLD
Role: PRINCIPAL_INVESTIGATOR
Fertility Center of San Antonio
Joseph Conaghan, Ph.D., HCLD
Role: PRINCIPAL_INVESTIGATOR
Pacific Fertility Center
Rodney Wade, BSA, MS, ELD
Role: PRINCIPAL_INVESTIGATOR
Southeastern Fertility Center
Kelvin L Fry, B. SC.
Role: PRINCIPAL_INVESTIGATOR
Florida Fertility Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pacific Fertility Center
San Francisco, California, United States
Florida Fertility Institute
Clearwater, Florida, United States
Southeastern Fertility Center
Mt. Pleasant, South Carolina, United States
Fertility Center of San Antonio
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IBS 001 20080202
Identifier Type: -
Identifier Source: org_study_id